Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • US Politics
    US Politics
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

Article Tools/Herramientas de artículos

+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña




Send2Press NewsWire Distribution Service

SAN FRANCISCO, Calif., Jan. 30, 2025 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the longest-serving publishing and market intelligence firm covering the neuromodulation industry, announced the launch of its first European management and investment conference. The two-day event, called Neurotech Leaders Forum at imec, will take place on June 3-4, 2025 on the campus of imec in Leuven, Belgium. Imec, a world-leading research and innovation center in nanoelectronics and digital technologies, is deeply committed to advancing health innovations through the power of semiconductor technologies, making it the ideal host for the conference.
Newswire: Neurotech Reports Announces First European Leaders Forum


Posted: 2025-01-30 12:00:39

Get Full News Story On Send2Press Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related Bing News Search Results

Newswire: Neurotech Reports Announces First European Leaders Forum - Newscast

Helius Medical Technologies Announces Reverse Stock Split - The Toronto Star

Thu, 26 Jun 2025 17:00:00 GMT NEWTOWN, Pa., June 27, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...

Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Netherton Syndrome | The ... - The Manila Times

Mon, 19 May 2025 16:59:00 GMT ASHBURN, Va., May 20, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company” or "Quoin”), a late clinical stage, specialty pharmaceutical company focused on rare and orphan ...

OptiSigns Announces European Expansion - Morningstar

Wed, 14 May 2025 20:00:00 GMT OptiSigns Announces European Expansion. PR Newswire. HOUSTON, May 15, 2025. ... We provide a platform for our authors to report on investments fairly, accurately, and ...

XORTX Announces Grant of European Patent - Yahoo Finance

Mon, 28 Apr 2025 00:00:00 GMT Patent Supporting Gout and Autosomal Dominant Polycystic Kidney Disease ProgramsCALGARY, Alberta, April 28, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ ...

AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis - Morningstar

Mon, 07 Apr 2025 17:00:00 GMT PR Newswire. NORTH CHICAGO, Ill., April 8, 2025. RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell ...
Blow Us A Whistle




Related Product Search/Búsqueda de productos relacionados